Questions about Residual Cell Viability in Cryopreserved Human Amniotic Membrane and Its Impact on Clinical Applications

7Citations
Citations of this article
6Readers
Mendeley users who have this article in their library.

Abstract

We questioned the relevance of evaluating residual cell viability in human amniotic membrane (hAM) after its cryopreservation since cell survival is controversial and its ability to act as a matrix (including the presence of growth factors and cytokines) appears to be most important for tissue regeneration purposes. We also discussed the usefulness of osteodifferentiating amniotic cells in whole hAM for bone repair applications. We have evidence that determining residual cell viability after cryopreservation and hAM osteodifferentiation is not justified.

Cite

CITATION STYLE

APA

Gaudet, C., Solecki, L., Mathéaud, B., Odet, S., Meyer, C., Louvrier, A., & Gindraux, F. (2022). Questions about Residual Cell Viability in Cryopreserved Human Amniotic Membrane and Its Impact on Clinical Applications. Biomedicines, 10(10). https://doi.org/10.3390/biomedicines10102456

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free